(NewsDirect)
Proactive research analyst Daniel Appiahspeaks to Thomas Warner at the London studio about his latest reportinto specialist contract research organisation hVIVO. hVIVO isexpanding its presence by establishing a cutting-edge facility at theCanary Wharf Life Sciences Hub in London.
The expansion, primarily funded by its clients, will featurestate-of-the-art amenities, including quarantine rooms, laboratories,outpatient facilities, and corporate offices all under one roof.Notably, the new site will initially offer 50 quarantine beds, withplans to expand to 70, significantly surpassing the currentWhitechapel and Queen Mary facilities, which can accommodate only43.
The move enables hVIVO toconduct simultaneous challenge trials for various clients, enhancingefficiency and increasing revenue. hVIVO's H1 results showcased aremarkable 52% YoY revenue increase to approximately £27.3 million,driven by the growth of their challenge trial order book. With astrong cash position and a prepayment model, the company appears setto meet its 2023 revenue guidance of £53 million with an EBITDAbetween 15% and 90%.
For more details, you can read Daniel'scomprehensive report by following the link in thecorner.
Contact Details
Proactive UKLtd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.